Dietary Requirement for Vitamin D in Adolescents Aged 14-18 Years
NCT ID: NCT02150122
Last Updated: 2016-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2014-10-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
No intervention studies have comprehensively investigated the vitamin D requirements of adolescents. The proposed ODIN Study will enable a better understanding of how adolescents respond to vitamin D supplementation and the most effective daily amount that will raise and maintain vitamin D status in adolescents during the winter-time. In addition, investigations into the mechanisms of action with respect to any differences observed across the doses of vitamin D and between the genders of the participants will also provide key information. Mechanisms of action will focus on genetic differences as well as differences in vitamin D metabolising enzymes.
The results obtained from this significant study will not only inform the European Food Standards Agency (EFSA) with respect to their imminent deliberations regarding vitamin D recommendations. The ODIN Study will also inform the UK Department of Health's Scientific Advisory Committee on Nutrition (SACN), the wider scientific community and be a critical resource for key stakeholders (i.e. food industry, government health agencies) to collaborate in determining future public health strategies, thus potentially positively impacting on the health of the population for years to come.
The investigators propose that the daily supplementation of 10µg/day (400 IU) and 20µg/day (800 IU) of vitamin D3 for five months will meet the vitamin D requirements of males and females aged 14-18 year and will be sufficient to maintain winter-time 25OHD levels above a range of thresholds between 30 and 50nmol/l.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Vitamin D Supplements on Vitamin D Status, Cardiometabolic Health and Immune Defense in Danish Children
NCT02145195
An Intervention Study to Investigate the Effect of B-vitamin Supplementation for 2-years on Bone Health
NCT03892395
Efficacy of Daily Vitamin D3 Supplementation in Normal Weight Adolescents
NCT01058720
Vitamin D Needs of Early Adolescent Children
NCT00931580
Inter-relationship Between Vitamin D Requirements and Calcium Intake in Older Adults
NCT01990872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
10 micrograms (400 IU) vitamin D3
Participants will be given a daily supplement containing 10 micrograms (400 IU) vitamin D3 to take for 5 months.
Vitamin D3
20 micrograms (800 IU) vitamin D3
Participants will be given a daily supplement containing 20 micrograms (800 IU) vitamin D3 to take for 5 months.
Vitamin D3
Placebo
Participants will be given a placebo, similar in appearance to the vitamin D3 tablets, to take for 5 months.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D3
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 14 and 18 years
* Caucasian ethnicity
* In good health
* Written informed consent from the adolescent (and parent if required)
Exclusion Criteria
* Hypercalcaemia (\>2.5mmol/l)
* Regular use of sun-beds
* Having a sun holiday one month prior to commencing the trial or plans for a sun holiday within the study period.
* Use of vitamin supplements containing vitamin D - if the prospective participant agrees to stop vitamin D supplementation to join the study, a wash-out period of 8 weeks prior to commencing the trial would be acceptable.
* Excessive consumption of alcohol (\>14 units per week for females, \>21 units per week for males)
* Smoking \>10 cigarettes per day
* Those following a weight-reducing diet or under dietary restriction (except vegetarianism)
* Known intolerance/allergy to the constituent ingredients of the daily supplement
* Clinically significant haematological abnormalities other than mild anaemia (Hb\<12.0g/dl)
* Active malignancy
* Pregnant or planning a pregnancy during the study period.
* Breast-feeding mothers
14 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Surrey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan Lanham-New, Professor
Role: PRINCIPAL_INVESTIGATOR
University of Surrey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Surrey
Guildford, Surrey, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Smith TJ, Tripkovic L, Hauger H, Damsgaard CT, Molgaard C, Lanham-New SA, Hart KH. Winter Cholecalciferol Supplementation at 51 degrees N Has No Effect on Markers of Cardiometabolic Risk in Healthy Adolescents Aged 14-18 Years. J Nutr. 2018 Aug 1;148(8):1269-1275. doi: 10.1093/jn/nxy079.
Smith TJ, Tripkovic L, Damsgaard CT, Molgaard C, Ritz C, Wilson-Barnes SL, Dowling KG, Hennessy A, Cashman KD, Kiely M, Lanham-New SA, Hart KH. Estimation of the dietary requirement for vitamin D in adolescents aged 14-18 y: a dose-response, double-blind, randomized placebo-controlled trial. Am J Clin Nutr. 2016 Nov;104(5):1301-1309. doi: 10.3945/ajcn.116.138065. Epub 2016 Sep 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ODIN/1213
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.